ab33171 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab33171 は 2 報の論文で使用されています。

  • Megiorni F  et al. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells. J Hematol Oncol 10:161 (2017). WB ; Human . PubMed: 28985758
  • Patel Y  et al. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Thromb Haemost 79:177-85 (1998). PubMed: 9459345

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録